Yanhua Xuan

1.2k total citations
47 papers, 884 citations indexed

About

Yanhua Xuan is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yanhua Xuan has authored 47 papers receiving a total of 884 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 24 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Yanhua Xuan's work include Cancer Cells and Metastasis (22 papers), Hedgehog Signaling Pathway Studies (10 papers) and Epigenetics and DNA Methylation (10 papers). Yanhua Xuan is often cited by papers focused on Cancer Cells and Metastasis (22 papers), Hedgehog Signaling Pathway Studies (10 papers) and Epigenetics and DNA Methylation (10 papers). Yanhua Xuan collaborates with scholars based in China, South Korea and United States. Yanhua Xuan's co-authors include Zhaoting Yang, Yan Cui, Chengye Zhang, Weidong Ni, Wenbo Qi, Zhenhua Lin, Longyun Fang, Nan Che, Haoyue Li and Ying Feng and has published in prestigious journals such as PLoS ONE, Oncogene and Scientific Reports.

In The Last Decade

Yanhua Xuan

47 papers receiving 879 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanhua Xuan China 18 539 381 221 115 111 47 884
Eva Allonca Spain 23 570 1.1× 410 1.1× 269 1.2× 158 1.4× 114 1.0× 46 1.1k
Christine Mehner United States 14 423 0.8× 339 0.9× 284 1.3× 77 0.7× 96 0.9× 23 849
Gvantsa Kharaishvili Czechia 18 404 0.7× 347 0.9× 221 1.0× 153 1.3× 62 0.6× 26 776
Femke Hillen Netherlands 8 531 1.0× 349 0.9× 321 1.5× 114 1.0× 154 1.4× 9 882
Aude Mallavialle France 15 409 0.8× 337 0.9× 161 0.7× 57 0.5× 184 1.7× 23 791
Aizhen Xiao United States 15 393 0.7× 189 0.5× 253 1.1× 90 0.8× 84 0.8× 21 773
Madelon Paauwe Netherlands 13 456 0.8× 380 1.0× 261 1.2× 114 1.0× 131 1.2× 16 805
Federica Ruffini Italy 20 637 1.2× 461 1.2× 197 0.9× 55 0.5× 178 1.6× 30 936
Eva Andreuzzi Italy 14 377 0.7× 155 0.4× 160 0.7× 74 0.6× 120 1.1× 25 671
Yongfen Min United States 18 519 1.0× 330 0.9× 269 1.2× 98 0.9× 126 1.1× 29 937

Countries citing papers authored by Yanhua Xuan

Since Specialization
Citations

This map shows the geographic impact of Yanhua Xuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanhua Xuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanhua Xuan more than expected).

Fields of papers citing papers by Yanhua Xuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanhua Xuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanhua Xuan. The network helps show where Yanhua Xuan may publish in the future.

Co-authorship network of co-authors of Yanhua Xuan

This figure shows the co-authorship network connecting the top 25 collaborators of Yanhua Xuan. A scholar is included among the top collaborators of Yanhua Xuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanhua Xuan. Yanhua Xuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gong, Jie, et al.. (2025). SETD5 facilitates stemness and represses ferroptosis via m6A-mediating PKM2 stabilization in non-small cell lung cancer. Oncogene. 44(29). 2474–2489. 1 indexed citations
2.
Che, Nan, et al.. (2023). Macelignan prevents colorectal cancer metastasis by inhibiting M2 macrophage polarization. Phytomedicine. 122. 155144–155144. 15 indexed citations
3.
Kim, Min Seong, et al.. (2023). SETD5 regulates the OGT-catalyzed O-GlcNAcylation of RNA polymerase II, which is involved in the stemness of colorectal cancer cells. Scientific Reports. 13(1). 19885–19885. 2 indexed citations
4.
Yang, Zhaoting, et al.. (2022). SETD5 Regulates Glycolysis in Breast Cancer Stem-Like Cells and Fuels Tumor Growth. American Journal Of Pathology. 192(4). 712–721. 18 indexed citations
5.
Li, Xiaogang, et al.. (2022). Tenascin C regulates cancer cell glycolysis and tumor progression in prostate cancer. International Journal of Urology. 29(6). 578–585. 8 indexed citations
6.
Yang, Zhaoting, et al.. (2021). B7-H4 induces epithelial–mesenchymal transition and promotes colorectal cancer stemness. Pathology - Research and Practice. 218. 153323–153323. 14 indexed citations
7.
Zhang, Chengye, Zhaoting Yang, Tae‐Su Jang, et al.. (2020). 3D culture technologies of cancer stem cells: promising ex vivo tumor models. Journal of Tissue Engineering. 11. 2752662815–2752662815. 55 indexed citations
8.
Che, Nan, Zhaoting Yang, Mengxuan Li, et al.. (2020). Suppression of LETM1 inhibits the proliferation and stemness of colorectal cancer cells through reactive oxygen species–induced autophagy. Journal of Cellular and Molecular Medicine. 25(4). 2110–2120. 19 indexed citations
9.
Yang, Zhaoting, et al.. (2020). Tenascin-C predicts poor outcomes for patients with colorectal cancer and drives cancer stemness via Hedgehog signaling pathway. Cancer Cell International. 20(1). 122–122. 21 indexed citations
10.
Qi, Wenbo, Zhaoting Yang, Ying Feng, et al.. (2020). Gli1 regulates stemness characteristics in gastric adenocarcinoma. Diagnostic Pathology. 15(1). 60–60. 9 indexed citations
12.
Piao, Longzhen, et al.. (2019). LETM1 is a potential biomarker of prognosis in lung non-small cell carcinoma. BMC Cancer. 19(1). 898–898. 16 indexed citations
13.
Li, Haoyue, et al.. (2019). LETM1 is a potential biomarker that predicts poor prognosis in gastric adenocarcinoma. Experimental and Molecular Pathology. 112. 104333–104333. 16 indexed citations
14.
Yang, Zhaoting, Chengye Zhang, Wenbo Qi, Yan Cui, & Yanhua Xuan. (2018). GLI1 promotes cancer stemness through intracellular signaling pathway PI3K/Akt/NFκB in colorectal adenocarcinoma. Experimental Cell Research. 373(1-2). 145–154. 53 indexed citations
15.
Yang, Zhaoting, et al.. (2018). Gli1, a potential cancer stem cell marker, is strongly associated with prognosis in prostate cancer.. PubMed. 11(10). 4957–4966. 14 indexed citations
16.
17.
Piao, Longzhen, et al.. (2018). B7H4 is associated with stemness and cancer progression in esophageal squamous cell carcinoma. Human Pathology. 80. 152–162. 26 indexed citations
18.
Yang, Zhaoting, et al.. (2018). Tenascin-C as a prognostic determinant of colorectal cancer through induction of epithelial-to-mesenchymal transition and proliferation. Experimental and Molecular Pathology. 105(2). 216–222. 33 indexed citations
19.
Ni, Weidong, et al.. (2017). Gli1 is a potential cancer stem cell marker and predicts poor prognosis in ductal breast carcinoma. Human Pathology. 69. 38–45. 8 indexed citations
20.
Zhao, Yiwei, Hai Lin, Danhua Shen, Yanhua Xuan, & Zhenhua Lin. (2008). Distribution of HPV genotypes in uterine cervical lesions in Yanbian, northern China. Pathology International. 58(10). 643–647. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026